Zhuhai Rundu Pharmaceutical Co Ltd - Class A

SZSE:002923 (China)   Class A
Â¥ 10.89 (-0.18%) May 17
64.06
P/B:
3.02
Market Cap:
Â¥ 3.65B ($ 504.82M)
Enterprise V:
Â¥ 4.02B ($ 557.03M)
Volume:
3.01M
Avg Vol (2M):
4.38M
Volume:
3.01M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Zhuhai Rundu Pharmaceutical Co Ltd ( ) from 2018 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zhuhai Rundu Pharmaceutical stock (SZSE:002923) PE ratio as of May 17 2024 is 64.06. More Details

Zhuhai Rundu Pharmaceutical Co Ltd (SZSE:002923) PE Ratio (TTM) Chart

To

Zhuhai Rundu Pharmaceutical Co Ltd (SZSE:002923) PE Ratio (TTM) Historical Data

Total 1186
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Zhuhai Rundu Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-17 64.1 2024-03-11 56.8
2024-05-17 64.1 2024-03-08 59.8
2024-05-16 64.2 2024-03-07 58.1
2024-05-15 64.9 2024-03-06 62.1
2024-05-14 65.7 2024-03-05 56.5
2024-05-13 66.9 2024-03-04 51.4
2024-05-10 66.1 2024-03-01 46.7
2024-05-09 67.7 2024-02-29 45.6
2024-05-08 67.8 2024-02-28 44.5
2024-05-07 67.1 2024-02-27 48.0
2024-05-06 65.3 2024-02-26 47.5
2024-04-30 63.9 2024-02-23 48.0
2024-04-29 62.8 2024-02-22 45.5
2024-04-26 60.0 2024-02-21 43.5
2024-04-25 60.3 2024-02-20 43.7
2024-04-24 60.0 2024-02-19 41.2
2024-04-23 59.0 2024-02-08 39.7
2024-04-22 58.0 2024-02-07 36.1
2024-04-19 58.1 2024-02-06 38.4
2024-04-18 57.7 2024-02-05 38.6
2024-04-17 59.5 2024-02-02 43.0
2024-04-16 54.3 2024-02-01 45.5
2024-04-15 57.9 2024-01-31 46.1
2024-04-12 60.9 2024-01-30 48.8
2024-04-11 61.1 2024-01-29 50.9
2024-04-10 60.9 2024-01-26 52.2
2024-04-09 62.0 2024-01-25 52.3
2024-04-08 60.4 2024-01-24 49.7
2024-04-03 63.1 2024-01-23 49.8
2024-04-02 63.5 2024-01-22 50.0
2024-04-01 64.7 2024-01-19 54.0
2024-03-29 62.3 2024-01-18 54.7
2024-03-28 60.9 2024-01-17 55.8
2024-03-27 51.0 2024-01-16 57.4
2024-03-26 51.6 2024-01-15 58.0
2024-03-25 52.0 2024-01-12 58.2
2024-03-22 54.5 2024-01-11 58.8
2024-03-21 54.6 2024-01-10 58.5
2024-03-20 55.4 2024-01-09 58.9
2024-03-19 55.3 2024-01-08 59.0
2024-03-18 56.1 2024-01-05 60.8
2024-03-15 55.1 2024-01-04 61.8
2024-03-14 56.0 2024-01-03 62.5
2024-03-13 57.9 2024-01-02 62.2
2024-03-12 58.3 2023-12-29 61.7

Zhuhai Rundu Pharmaceutical Co Ltd (SZSE:002923) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Zhuhai Rundu Pharmaceutical Co Ltd is engaged in the production and sales of chemical drugs, chemical raw materials, and pharmaceutical intermediates. Its products offerings include APIs medicine, Pellets, intermediate and formulations.